LOS ANGELES, Oct. 21, 2025 (GLOBE NEWSWIRE) — GLD Partners, LP, with a growing footprint of investments in life sciences, healthcare, and biotech, today announced the successful acquisition of select assets from Seelos Therapeutics, Inc. through the Chapter 11 bankruptcy process. Following its acquisition of Seelos' senior secured debt, GLD served as the stalking horse […]
(NYSE MKT:GNS), SINGAPORE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that it is the Title Sponsor of Coindesk's Bitcoin Treasury Theme Month, with 100 million Satoshis (equal to one Bitcoin) in prize money. CoinDesk, a leading site
(NASDAQ:GSM), LONDON, Oct. 21, 2025 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ: GSM) announced today that it will issue third quarter 2025 financial results after the market closes on Wednesday, November 5, 2025, and will host the quarterly earnings call on Thursday, November 6, 2025, at 8:30 a.m. Eastern Time. To join via phone: Conference call
(NASDAQ:BNC),(NASDAQ:BNCWW), Louisville, CO, Oct. 21, 2025 (GLOBE NEWSWIRE) — CEA Industries Inc. (Nasdaq: BNC) (“BNC” or the “Company”) today announced that it now holds a total of 500,000 BNB tokens, with an average acquisition cost of approximately $870 per BNB, representing a total invested amount of $435 million and an estimated BNB value of $546.8million
(Other OTC:PETV),(OTC US:PETV),(OTC US:PETVW),(Other OTC:PETVW), MINNEAPOLIS, Oct. 21, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQX: PETV; OTCID PETVW), in cooperation with its wholly-owned subsidiary PetVivo Animal Health, Inc., an emerging biomedical device company focused on the commercialization of groundbreaking medical products for horses and companion animals, today announced it has entered into an exclusive
Investor-focused update underscores enrollment momentum, biomarker strategy, and near-term data readouts designed to de-risk development of (Z)-Endoxifen and other endocrine therapies for DCIS Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD, MBA, Professor of Surgery and Radiology at
(NASDAQ:SBET), Minneapolis, MN, Oct. 21, 2025 (GLOBE NEWSWIRE) — SharpLink Gaming, Inc. (Nasdaq: SBET) (“SharpLink” or the “Company”), one of the world's largest corporate holders of Ether (“ETH”) and prominent industry advocate of Ethereum adoption, today announced that as of October 19, 2025, SharpLink's total ETH holdings increased to 859,8531, reflecting the Company's continued commitment
DALLAS, Oct. 21, 2025 (GLOBE NEWSWIRE) — Solenic Medical, a medical device company developing an innovative treatment for orthopedic implant infections, today announced the successful, FDA-authorized compassionate use of its investigational Alternating Magnetic Field (AMF) technology. The noninvasive AMF treatment was delivered as an adjunct to surgery in a patient with a serious medical condition
Research Triangle Park, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — First-in-human trial of investigational gene therapy AB-1002 designed to evaluate safety and preliminary efficacy in participants with New York Heart Association (NYHA) Class III heart failure No adverse events were deemed related to AB-1002, and clinically meaningful improvement of several efficacy assessments was seen in
(NasdaqGM:CSLR),(NasdaqGM:SPWR),(NASDAQ:SPWRW), OREM, Utah, Oct. 21, 2025 (GLOBE NEWSWIRE) — SunPower, the “Company,” or Nasdaq: “SPWR”, a solar technology, services, and installation company, will present its Q3'25 results via webcast today Tuesday, October 21 at 1:00pm ET. Interested parties may access the webcast by registering here or by visiting the Events page within the IR section